Return the favour: South Korea looks to U.S. for COVID-19 vaccine aid

South Korea hopes the United States will help it tackle a shortage of coronavirus vaccine in return for test kits and masks Seoul sent to Washington earlier in the pandemic, the foreign minister said on Wednesday.

The government has drawn fire from the media for not doing enough to secure enough vaccines early, with just 3% of the population inoculated, due to tight global supply and limited access.

“We have been stressing to the United States that ‘A friend in need is a friend indeed,'” the minister, Chung Eui-yong, told reporters at the Kwanhun Club of South Korean journalists.

He said South Korea had airlifted Washington a large volume of coronavirus test kits and face masks in the early stages of the pandemic “in the spirit of the special South Korea-U.S. alliance,” despite tight domestic supply at the time.

“We are hoping that the United States will help us out with the challenges we are facing with the vaccines, based on the solidarity we demonstrated last year.”

The allies were in talks, added Chung, who also flagged South Korea’s potential contribution to preserving a global semiconductor supply chain U.S. President Joe Biden is keen to maintain.

Diplomatic efforts have not yielded any concrete steps, however, as the talks with Washington are still in an early stage, health ministry official Son Young-rae told reporters.

Opposition lawmaker Park Jin urged more aggressive vaccine diplomacy, calling for the government to invoke its free trade pact (FTA) with Washington to secure pharmaceutical products.

“The government needs to be more proactive,” Park told Reuters.

“The FTA provides us a legal base to demand (vaccines) as it stipulates the two countries’ commitment to promoting the development of, and facilitating access to, pharmaceutical products.”

The U.S. embassy in Seoul did not immediately reply to a Reuters’ request for comment.

About 1.77 million people in South Korea have had their first dose of the AstraZeneca Plc (AZN.L) or Pfizer (PFE.N) vaccines. The low rate compares with a 40% vaccination rate in the United States, according to Reuters data.

Tuesday’s 731 new coronavirus infections, up from 549 cases a day earlier, took South Korea’s tally to 115,926, with 1,806 deaths.

(Global vaccination tracker: https://graphics.reuters.com/world-coronavirus-tracker-and-maps/vaccination-rollout-and-access/)

Our Standards: The Thomson Reuters Trust Principles.

Source: https://www.reuters.com/world/asia-pacific/return-favour-south-korea-looks-us-covid-19-vaccine-aid-2021-04-21/

World Economic Magazine

Recent Posts

Historic deal positions FIA World Endurance Championship for record decade of growth as the sport enters its golden age

FIA President Mohammed Ben Sulayem hails new agreement as a vital step forward for racing…

2 days ago

Alpaca and Indonesia Stock Exchange Move to Connect Indonesian Investors With Global Markets

Indonesia’s rapidly expanding investor community is creating a new opportunity for financial technology companies: connecting…

4 days ago

Roseman Bioventures Strengthens Nevada’s Life Sciences Ambitions With New Leadership

Nevada’s emergence as a life sciences destination is gaining momentum, and Roseman Bioventures is positioning…

5 days ago

Hyperion and CADDi Target a Hidden Manufacturing Bottleneck: The Cost of Slow Quotations

Hyperion Materials & Technologies is working with CADDi to centralise engineering data and accelerate quotation…

6 days ago

Starting a Business in Ontario? Understanding the Financial Steps to Get You Started

Launching a business in Ontario is an exciting but strategic endeavour that begins with a…

6 days ago

Sonos Expands Its Connected Audio Ecosystem With Beam Ultra and Ace Ultra

The next stage of premium consumer electronics is increasingly about ecosystems rather than individual devices.…

7 days ago